View Author
patient vaccination group chemotherapy cancer flipi fluenza prognostic study response patient group prognostic index lymphoma virus model vaccine signi signi ficantly survival fluenza vaccination index comorbidity antibody treatment patients vaccinated control breast factor disease cycle breast cancer patients breast cancer chemotherapy cycle value table number score level article annals oncology strain erasmus universiteit rotterdam 10- year os stage fluenza virus vaccination vaccinated titre netherland control group prognosis serum article validation eindhoven 60 years cancer patients eindhoven cancer registry infection population-based risk groups signi ficant centre department /brisbane hospital ficant annals vaccination group post-vaccination cohort presence ficantly 10- flipi score result risk factors day 16 sample volume medicine
2 Most Recent Publications
|
Response to influenza virus vaccination during chemotherapy in patients with breast cancer
(Article)
Meerveld-Eggink, A. de Weerdt, O. Rijkers, G.T. Biesma, D.H. Velden, A.M.T. van der Los, M. Stouthard, J.M.L. Nijziel, M.R. Westerman, M. Beeker, A. Beek, R.H.T. van Rimmelzwaan, G.F. |
2011-09-01
|
|
Validation, revision and extension of the follicular lymphoma international prognostic index (FLIPI) in a population-based setting
(Article)
Schans, S.A.M. van de Steyerberg, E.W. Nijziel, M.R. Creemers, G.J.M. Janssen-Heijnen, M.L.G. Spronsen, D.J. van |
2009-10-09
|
